REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/16/2026
Back to search
Official data from USPTO
SANFER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
03/17/2026
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
03/23/2020
Registration date
03/16/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/16/2021
Last transaction
03/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
Col. Tlacopac, MX
Examiner
FERRAIUOLO, DOMINIC
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "SANFER" in stylized form.
Holders and representatives
Holders
Laboratorios Sanfer, S.A. de C.V.
Representatives
John M. Murphy
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines and pharmaceutical preparationspharmaceutical and medicinal products for ophthalmic useantipyreticsanalgesicsanestheticsantiallergic medicinesantihistaminesantidotesarsenic detoxification agents for medical purposesbenzol detoxification agents for medical purposeschlorine detoxification agents for medical purposesopium alkaloid preparationssmoking cessation preparationspharmaceutical preparationsantineoplastic and immunomodulating agentsanti-cancer preparationsanti-arthritic compositions and preparationsantiphlogistic analgesicsanti-rheumaticpharmaceutical preparations for inhalation for the treatment of pulmonary hypertensionsantitussivesexpectorantsinhalant anestheticscardiovascular treatment preparationsanalepticspharmaceutical preparations for treating hypertensionantibacterial pharmaceuticalspharmaceutical preparations for the treatment of heart rhythm disordersantihypertensivesvasodilatorschemotherapeuticsantibiotic preparationsantifungal preparationsanti-tuberculous preparationsanti-leprotic agentsanti-protozoa preparationsmedicinal preparations used in the treatment of malariaantiviralsantiparasitic preparationsdermatological pharmaceutical productsantiparasitic preparationsdermatologicsradio-isotope markers for therapeutic or diagnostic usedietary supplementsdisinfectantsdiuretics and anti-diureticsantianemia drugsanticoagulantspreparations for transfusionsenzymes for medical purposesenzyme inhibitorsnutraceuticals for use as a dietary supplement for liver supportmedicines for treatment of gastrointestinal diseasesantacidsdiarrhea medicationanthelminticsemeticsanti-emetic pharmaceutical preparationsmedicated mouthwash for treating ulcersantiflatulentsdigestives for pharmaceutical purposesmedicines for use in indigestionanti-inflammatorieslaxativesantisepticspharmaceutical preparations for the treatment and prevention of women's disorders and diseasesspecificallypharmaceutical preparations for assisted reproductive therapypharmaceutical preparations for the prevention and treatment of luteal phase defects and the prevention of miscarriagesimmunosuppressantsdietary and nutritional supplements for anabolic useantidiabetic preparationsdietary and nutritional supplements used for weight losspharmaceutical preparations for the treatment of anorexia; pharmaceutical agents affecting metabolismpharmaceutical preparations for the treatment of Parkinson's diseasehypnotic sedativesneurolepticstranquilizersantidepressantsanti-psychotic pharmaceutical preparationsanalepticsneuropathical agents and other neurotropic agentshormones for medical purposespoly-opotherapeutic curative preparations for postponing manifestations of agingestrogen preparationsprogestogenscontraceptive preparationsandrogen preparationsanti-hormone drugsotorhinolaryngological preparationsotorhinolaryngological serumsvaccinesantispasmodicsvitaminsdietary and nutritional supplements containing coenzyme q10multivitamin preparationspharmaceutical preparations for sublingual use for treatment of heart problems; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders
Publications
History of USPTO decisions and trademark events.
32 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/15/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/15/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/15/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/15/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/15/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/15/2024
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
07/12/2023
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
07/12/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/16/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/29/2020
PUBO
PUBLISHED FOR OPPOSITION
12/29/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/09/2020
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/24/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
11/10/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
10/30/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/27/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/26/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/26/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/26/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/15/2020
GNRT
NON-FINAL ACTION E-MAILED
07/15/2020
CNRT
NON-FINAL ACTION WRITTEN
07/15/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/23/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/22/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/22/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/18/2020
GNRT
NON-FINAL ACTION E-MAILED
06/18/2020
CNRT
NON-FINAL ACTION WRITTEN
06/18/2020
DOCK
ASSIGNED TO EXAMINER
06/15/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/26/2020
NWAP
NEW APPLICATION ENTERED
03/26/2020
Continuous trademark protection
Get notified about every new filing that threatens SANFER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.